Home Hydrothemal synthesis and crystal structure of triaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O;κ1O)manganese(II), C12H16N4O11Mn
Article Open Access

Hydrothemal synthesis and crystal structure of triaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O1O)manganese(II), C12H16N4O11Mn

  • Liu Guang-Zhen and Yan Meng-Zhen EMAIL logo
Published/Copyright: June 29, 2018

Abstract

C12H16N4O11Mn, triclinic, P1̄ (no. 2), a = 7.7186(3) Å, b = 9.8439(3) Å, c = 11.6084(3) Å, α = 104.288(3)°, β = 94.024(3)°, γ = 97.365(3)°, V = 842.93(5) Å3, Z = 2, Rgt(F) = 0.0322, T = 291 K.

CCDC no.: 844889

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colorless block
Size:0.35 × 0.29 × 0.27 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.86 mm−1
Diffractometer, scan mode:Supernova, φ and ω-scans
θmax, completeness:25°, >99%
N(hkl)measured, N(hkl)unique, Rint:14394, 2880, 0.031
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2709
N(param)refined:260
Programs:CrysAlisPRO [1], SHELX [2], OLEX2 [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Mn10.77286(4)0.58068(3)0.66268(3)0.02699(13)
O10.48902(19)0.56463(16)0.69480(13)0.0313(4)
O1W1.0479(2)0.58940(18)0.64937(15)0.0400(4)
H1WA1.06900.58860.57790.060
H1WB1.08120.51350.66020.060
O20.27823(19)0.47657(17)0.78836(14)0.0361(4)
O2W0.8310(2)0.76948(17)0.81111(15)0.0442(4)
H2WA0.73940.78230.84690.066
H2WB0.85300.84250.78440.066
O30.2524(2)0.32374(18)0.92858(15)0.0367(4)
H30.26410.37260.88100.055
O3W0.6959(2)0.38549(16)0.51154(13)0.0323(4)
H3WA0.62040.39950.45580.048
H3WB0.63510.31710.53570.048
O40.4184(2)0.21081(18)1.02283(15)0.0412(4)
O50.7062(3)0.69583(19)0.53944(16)0.0488(5)
O60.9500(2)0.7691(2)0.46879(18)0.0502(5)
O71.0381(2)0.9113(2)0.33200(19)0.0545(5)
H71.00390.85960.37400.082
O80.9176(3)1.0317(2)0.21897(17)0.0541(5)
N10.7366(2)0.44486(18)0.79222(15)0.0254(4)
N20.7219(2)0.30659(19)0.91609(15)0.0277(4)
N30.5053(2)0.83313(18)0.41636(15)0.0273(4)
N40.5862(2)0.97669(17)0.30359(15)0.0260(4)
C00I0.5676(3)0.4253(2)0.82085(17)0.0217(4)
C10.4356(3)0.4940(2)0.76408(18)0.0248(5)
C20.8237(3)0.3718(2)0.8507(2)0.0302(5)
H20.94260.36590.84710.036
C30.5547(3)0.3395(2)0.89804(17)0.0230(4)
C40.7874(3)0.2182(3)0.9899(2)0.0456(6)
H4A0.90890.21220.97990.068
H4B0.72030.12490.96550.068
H4C0.77580.26001.07240.068
C50.4030(3)0.2856(2)0.95499(18)0.0274(5)
C60.7866(3)0.7626(2)0.4770(2)0.0330(5)
C70.6822(3)0.8401(2)0.40923(18)0.0233(4)
C80.4534(3)0.9170(2)0.35272(19)0.0283(5)
H80.33790.93320.34280.034
C90.7360(3)0.9280(2)0.33806(17)0.0243(4)
C100.9066(3)0.9620(2)0.2921(2)0.0357(5)
C110.5663(4)1.0811(3)0.2346(2)0.0472(7)
H11A0.58501.04140.15300.071
H11B0.65091.16450.26800.071
H11C0.44991.10560.23770.071

Source of material

All chemicals were used as obtained without further purification. The mixture of 4,5-dicarboxyimidazole (H2mdci; 0.1 mmol, 17.1 mg), triazole (trz) (0.1 mmol, 7.0 mg) Mn(OAc)2⋅4H2O (0.2 mmol, 49.1 mg), and H2O (6.0 mL) was placed in 23 mL Teflon-lined autoclave, heated to 120 °C for 3 days, and then slowly cooled down. Colourless block-shaped crystals were obtained.

Comment

Design and construction of supramolecular chemistry have stimulated the interests of chemists over the past few decades, owing to their intriguing variety of architectures and their potential applications [4], [5], [6]. Polydentate organic ligands are good candidates for the construction of supramolecular complexes for their diversity in the coordination modes. The imidazole-(bi)carboxylic ligands with the manifold N– and O-donors are good candidates, which finally aggregate to various supramolecular architectures. Very interesting and promising results have been obtained by using imidazole dicarboxylic ligands as efficient linkers [7], [8]. To the best of our knowledge, plenty of transition metal-H2dci (4,5-dicarboxyimidazole) complexes have been documented so far [9], [10], [11]. In comparison with H2dci (4,5-dicarboxyimidazole), 4,5-dicarboxyl-1-methyl-1H-imidazole (H2mdci), as a derivative of H2dci, can probably provide the potential to enrich the unpredictable and interesting structural and functional diversities of network structures [10], [12]. In this paper, we have chosen the 4,5-dicarboxyl-1-methyl-1H-imidazole (H2mdci) as a bridging ligand, whereas 1,2,4-triazole (trz) as auxiliary ligand, successfully constructing new coordination complexes.

The asymmetric unit contains a crystallographically distinct Mn(II) cation, two uncompletely deprotonated Hmdci anions and three water molecules. The Mn1 is octahedrally coordinated by one N atom and two oxygen atoms from two Hmdci ligands, respectively, and three oxygen atoms from three water molecules. Two carboxylate groups from two different Hmdci ligands, the imidazolyl from Hmdci ligand and one water molecule comprise the equatorial basal plane. The other two water ligands occupy the apical sites. All the Mn—O bond lengths are in the range of 2.1078(16)–2.2406(15) Å, and the Mn—N bond distance is 2.2545(17) Å. One Hmdci ligand adopts a-k2N,O coordination mode. The other Hmdci ligand adopts monodentate coordination. The 4-position carboxylate O atom from each Hmdci ligand remains uncoordinated.

The H-bonding interactions play an important role in forming the resultant three-dimensional framework. There exist two hydrogen bonds in the complex O7⋯O6: 2.439(3) Å; O3⋯O2: 2.476(2) Å. There are many intermolecular hydrogen bonds that link the adjacent mononuclear units to a three-dimensional supramolecular network.

Award Identifier / Grant number: 21571093

Funding statement: This work was supported by the National Natural Science Foundation of China (No. 21571093).

References

Oxford Diffraction Ltd, CrysAlisPRO, Abingdon, Oxfordshire, England (2006).Search in Google Scholar

Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar

Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Search in Google Scholar

Gale, P. A.; Sessler, J. L.; Steed, J. W.: Supramolecular chemistry–introducing the latest web themed issue. Chem. Commun. 47 (2011) 5931–5932.10.1039/c1cc90048jSearch in Google Scholar

Harmon, K. M.; Gill, S. H.; Rasmussen, P. G.; Hardgrove Junior, G. L.: Inter- and intramolecular hydrogen bonding effects on the structure, solubility, and reactivity of 4,5-dicarboxyimidazoles. J. Mol. Struct. 478 (1999) 145–154.10.1016/S0022-2860(98)00669-3Search in Google Scholar

Janczak, J.; Kubiak, R.: Pyrazine control of the supramolecular chemistry of iron(II) and cobalt(II) phthalocyanines. CrystEngComm 12 (2010) 3599–3606.10.1039/c003440aSearch in Google Scholar

Das, S.; Karmakar, S.; Saha, D.; Baitalik, S.: A combined experimental and DFT/TD-DFT investigation of structural, electronic, and cation-induced switching of photophysical properties of bimetallic Ru(II) and Os(II) complexes derived from imidazole-4,5-dicarboxylic acid and 2,2′-bipyridine. Inorg. Chem. 52 (2013) 6860–6879.10.1021/ic302566pSearch in Google Scholar PubMed

Gu, Z. G.; Liu, Y. T.; Hong, X. J.; Zhan, Q. G.; Zheng, Z. P.; Zheng, S. R.; Li, W. S.; Hu, S. J.; Cai, Y. P.: Construction of metal-imidazole-based dicarboxylate networks with topological diversity: thermal stability, gas adsorption, and fluorescent emission properties. Cryst. Growth Des. 12 (2012) 2178–2186.10.1021/cg2002095Search in Google Scholar

Fang, R. Q.; Zhang, X. M.: Diversity of coordination architecture of metal 4,5-dicarboxyimidazole. Inorg. Chem. 45 (2006) 4801–4810.10.1021/ic052099mSearch in Google Scholar PubMed

Plieger, P. G.; Ehler, D. S.; Duran, B. L.; Taylor, T. P.; John, K. D.; Keizer, T. S.; Mark McCleskey, T.; Burrell, A. K.; Kampf, J. W.; Haase, T.; Rasmussen, P. G.; Karr, J.: Novel binding of beryllium to dicarboxyimidazole-based model compounds and polymers. Inorg. Chem. 44 (2005) 5761–5769.10.1021/ic050680cSearch in Google Scholar PubMed

Fang, R. Q.; Zhang, X. H.; Zhang, X. M.: A NaCl-like metal-organic framework constructed by unprecedented tetrahedral Cd4O6 and Cd5O6 units. Cryst. Growth Des. 6 (2006) 2637–2639.10.1021/cg060408tSearch in Google Scholar

Smith, T. S.; Root, C. A.; Kampf, J. W.; Rasmussen, P. G.; Pecoraro, V. L.: Reevaluation of the additivity relationship for vanadyl-imidazole complexes: correlation of the EPR hyperfine constant with ring orientation. J. Am. Chem. Soc. 122 (2000) 767–775.10.1021/ja991552oSearch in Google Scholar

Received: 2018-03-06
Accepted: 2018-05-23
Published Online: 2018-06-29
Published in Print: 2018-08-28

©2018 Liu Guang-Zhen et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure of 2-amino-4-(2,4-dinitrophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo-pyran, C18H16N4O6
  3. Crystal structure of catena-poly[(μ3-5-carboxy-2-(pyridin-4-yl)benzoato-κ5O,O′:O′′,O′′′:O′′′)(1,10-phenanthroline-κ2N,N′)cadmium(II)], C100H60N12O16Cd4
  4. Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C19H18N2O6
  5. Crystal structure of 1-{4-[(2-hydroxy-5-methyl benzylidene)amino]phenyl}ethanone O-ethyl-oxime, C18H20N2O2
  6. Crystal structure of bis{4-methyl-2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O)}copper(II), C36H38CuN4O4
  7. Crystal structure of bis{5-methoxy-2-((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}nickel(II), C34H34N4NiO6
  8. Crystal structure of poly[μ8-3-carboxyphthalat-κ8-O:O1,O1,O1:O2:O3,O3:O4)silver(I)], C9H4Ag2O6
  9. Crystal structure of 2-((E)-((4-((E)-1-(hydroxyimino)ethyl)phenyl)iminio)methyl)-5-methoxyphenolate, C16H16N2O3
  10. Crystal structure of (E)-1-(4-(((E)-2-hydroxy-3-methoxybenzylidene)amino)phenyl)ethan-1-one oxime, C16H16N2O3
  11. The crystal structure of 2-(tert-butyl)-4-chloro-6-phenyl-1,3,5-triazine, C13H14Cl1N3
  12. Crystal structure of (6,6′-(((((2-aminoethyl)azanediyl)bis(ethane-2,1-diyl))bis(azanylylidene))bis(methanylylidene))bis(2,4-dichlorophenolato)-κ6N,N′,N′′,N′′′,O,O′)cadmium(II) – ethanol – water (1/1/1), C22H28CdCl4N4O4
  13. Crystal structure of 6-chloro-N-methylpyrimidin-4-amine, C5H6ClN3
  14. Synthesis and crystal structure of bis{((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)-2-naphtholato-κ2N,O}nickel(II), C40H34N4NiO4
  15. Crystal structure of (E)-2-(4-bromophenyl)ethenesulfonyl fluoride (C8H6BrFO2S)
  16. Synthesis and crystal structure of 2,2′-ethylenedioxybis(benzimide)-2,2′-bis[O-(1-propyloxyamide)]oxime-4,4′,6,6′-tetrachlorodiphenol, C36H34Cl4N4O8
  17. Crystal structure of bis(N-(1-(pyrazin-2-yl)ethylidene)nicotinohydrazonato-κ3N,N′,O)cadmium(II) – methanol (1/1), C26H28N10O4Zn
  18. Crystal structure of diaqua-(N-(1-(pyrazin-2-yl)ethylidene)nicotinohydrazonato-κ3N,N′,O)-bis(nitrato-κ2O,O′)samarium(III), C12H14N7O9Sm
  19. Crystal structure of hexaaqua-{(E)-N′-(1-(pyrazin-2-yl)ethylidene)isonicotinohydrazide-κ3N,N′,O}praseodym(III) trichloride monohydrate, C12H25Cl3N5O8Pr
  20. Crystal structure of methyl 4-(3-cyanophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C21H22N2O3
  21. Crystal structure of ethyl 2-amino-4-(2-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO6
  22. Crystal structure of 2,12-dibromo-5,15-dihexyl-5,15-dihydrobenzo [1,2-b:5,6-c′]dicarbazole, C38H38Br2N2
  23. Crystal structure of ethyl 2-amino-4-(3-hydroxy-4-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO7
  24. Crystal structure of ethyl 2-amino-4-(3,4-dimethylphenyl)-5-oxo-4H,5H-pyrano[3,2-c] chromene-3-carboxylate, C23H21NO5
  25. Crystal structure of 2-hydroxy-N′-(pyrimidin-2-yl)benzohydrazide, C11H10N4O2
  26. Crystal structure of 2-(3,4-dimethylphenyl)-1,8-naphthyridine, C16H14N2
  27. Crystal structure of ethyl 4-(3,4-dimethylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C23H29NO3
  28. Crystal structure of ethyl 4-(3-cyanophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C22H24N2O3
  29. Crystal structure of 7β,9β-dihydroxy-15-oxo-ent-kauran-16-en-19,6β-olide, C20H26O5
  30. Crystal structure of Ent-7β,20-epoxy-kaur-16-en-1β,6α,7α,14α,15α-pentaol-20-one, C20H30O8
  31. Crystal structure of 1,4-bis(benzo[d][1,3]dioxol-5-ylmethyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-yl acetate, C22H20O8
  32. Crystal structure of methyl 2-((4-((2-nitrophenoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl) benzoate, C18H16N4O5
  33. Crystal structure of diaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O)zinc(II), C12H14N4O10Zn
  34. Hydrothemal synthesis and crystal structure of triaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O1O)manganese(II), C12H16N4O11Mn
  35. Redetermination of methyl 4-(4-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22ClNO3
  36. Crystal structure of bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-methyl-imdazol)-κN}-dithiocyano-κN-zinc(II) C24H22N12S2Zn
  37. Crystal structure of (5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl furan-2-carboxylate, C10H7FN2O5
  38. Crystal structure of bis(η6-cymene)-tri-μ2-chlorido-ruthenium(II) tetrafluoroborate, C20H28BCl3F4Ru2
  39. Crystal structure of 3,6-diphenyl-7H-[1,2,4]-triazolo[3,4-b][1,3,4]thiadiazine, C16H12N4S
  40. Synthesis and crystal structure of 1,3-bis[(3,4-dicyano)phenoxy]-4,6-dinitro-benzene, C22H8N6O6
  41. Crystal structure of ethyl 2-amino-4-(2,6-dichlorophenyl)-7-methyl-5-oxo-4H,5H-pyrano [4,3-b]pyran-3-carboxylate, C18H15Cl2NO5
  42. Crystal structure of poly[μ3-hydroxy-(μ5-(5-(2-carboxylatophenoxy)isophthalato-κ6O1:O2:O3:O4:O5,O6)-(μ2-1,4-di(1H-imidazol-1-yl)butane-κ2N:N′)dicobalt(II)] hemihydrate, C25H22Co2N4O8.5
  43. Crystal structure of methyl 4-(4-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C20H22BrNO3
  44. Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate trihydrate, C35H33NO12
  45. Crystal structure of 2,5-bis(4-(10H-phenothiazin-10-yl)phenyl)-1,3,4-oxadiazole, C38H24N4OS2
  46. The crystal structure of (E)-2-(4-hydroxyphenyl)-5-(prop-1-en-1-yl)benzofuran-3-carbaldehyde, C18H14O3
  47. Crystal structure of bis{5H-dibenzo[c,f][1,5]oxabismocin-12(7H)-yl} carbonate, C29H24O5Bi2
  48. Crystal structure of ethyl-5-formyl-3,4-dimethylpyrrole-2-carboxylate — N-(5-ethoxycarbonyl-3,4-dimethylpyrrole)-2-methylene-5-nitrobenzene-1,2-diamine (1:1), C26H31N5O7
  49. Crystal structure of (E)-2-(1-((2-aminophenyl)imino)ethyl)-6-bromo-4-chlorophenol, C14H12BrClN2O
  50. Crystal structure of (Z)-2-(4-chlorophenyl)-4-(furan-2-yl(phenylamino)methylene)-5-methyl-2,4-dihydro-3H-pyrazol-3-one, C21H16ClN3O2
  51. Crystal structure of N2,N4-dibutyl-6-chloro-N2,N4-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine, C31H58ClN7 – Important intermediate of Chimassorb 119 synthesis
  52. Crystal structure of 1-(5-bromo-2-(4-methoxyphenyl)-1H-indol-7-yl)ethanone oxime, C17H15BrN2O2
  53. Crystal structure of poly-{diaqua-bis[(μ2-3-nitrobenzenesulfonylglycine-κ3N:O:O′)(4,4′-bipyridine)manganese(II)]}-dimethylformamide (1/1), C39H35Mn2N9O15S2
  54. Crystal structure of 4-(dimethylamino)-1-(prop-2-yn-1-yl)pyridin-1-ium perchlorate, C10H13ClN2O4
  55. Crystal structure of 2-amino-5-oxo-4-(4-chloro-phenyl)-4,5,6,7-tetrahydro-cyclopenta[b]pyran-3-carbonitrile, C15H11ClN2O2
  56. Crystal structure of triaqua-(pyridine-2,6-dicarboxylato-κ3O,N,O′)cobalt(II) – 6-phenyl-1,3,5-triazine-2,4-diamine (1/1), C16H18CoN6O7
  57. Crystal structure of ethyl 2-amino-4-(3-cyanophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C21H22N2O4
  58. Crystal structure of 2-(4-chloro-2,6-dinitrophenyl)-1-(4-chloro-3-nitrophenyl)diazene 1-oxide, C12H5Cl2N5O7
  59. Crystal structure of 3,4-dimethyl-2,6-dinitrophenol, C8H8N2O5
  60. Crystal structure of 1,2-dimethyl-3,5-dinitrobenzene, C8H8N2O4
  61. Crystal structure of ethyl 4-(3-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C21H24ClNO3
  62. Crystal structure of N-(4-chlorophenyl)-2-(2,6-dichlorophenyl)acetamide, C14H10Cl3NO
  63. Crystal structure of 2-amino-4-(4-fluorophenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2c] chromene, C19H11FN2O3
  64. The crystal structure of (4-nitrophenyl) (5-ferrocenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl) methanone, C21H12F3FeN3O3
  65. Crystal structure of 5,5′-((3-hydroxy-4-methoxyphenyl)methylene)bis(1,3-diethyl-6-hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one), C24H30N4O6S2
  66. Crystal structure of (3aR,4R,5R,7R,8S,9R,9aS,12R)-7-ethyl-5-(1-hydroxy-2-((R)-3-hydroxypyrrolidin-1-yl)ethoxy)-4,7,9,12-tetramethyldecahydro-4,9a-propanocyclopenta[8]annulene-3,8-diol – a pleuromutilin derivative, C26H41NO5
  67. Crystal structure of bis(μ2-3-formyl-5-methoxy-2-oxidobenzoato-κ3O,O′:O′)-hexapyridine-dicadmium(II) – pyridine (1/1), C53H47Cd2N7O10
  68. Crystal structure of ethyl 2-amino-4-(3-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO6
  69. Crystal structure of methyl 4-(3,5-ditrifluoromethylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate — water (2/1), C22H21F6NO3
  70. Crystal structure of 2-(4-bromophenyl)-2,3-dihydro-1H-perimidine, C17H13BrN2
  71. Crystal structure of (5-ethyl-2-(4-methoxyphenyl)-1,3-dioxan-5-yl)methanol, C14H20O4
  72. Crystal structure of (E)-N-(4-bromo-2-(1-(hydroxyimino)ethyl)phenyl)benzamide, C15H13BrN2O2
  73. Crystal structure of caffeinium triiodide – caffeine (1/1), C16H21I3N8O4
  74. Crystal structure of methyl 2-methyl-4-(3-methoxyphenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C19H21NO4
  75. Crystal structure of (E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1-phenylprop-2-en-1-one, C23H28O2
  76. Crystal structure of 1,4-bis(2-azidoethyl)piperazine-1,4-diium dichloride, C8H18N8Cl2
  77. The crystal structure of dichlorido-(1,3-bis(2,6-dimethylphenyl)-1H-imidazol-2(3H)-ylidene)-(morpholine-κ1N)palladium(II), C23H29Cl2N3OPd(II)
  78. The crystal structure of 1-((5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-yl)methyl)-1,3-diphenylurea, C24H21ClN4O
  79. Crystal structure of 6-(2-bromoacetamido)tetrahydro-2H-pyran-2,3,4,5-Tetrayl tetraacetate, C16H22BrNO10
  80. Crystal structure of 5-methylpyrazine-2-carbohydrazide, C6H8N4O
  81. Crystal structure of catena-poly[(μ2-5-(tert-butyl)isophthalato-κ4O,O′:O′′,O′′′)(-4′-(pyridin-4-yl)-2,2′:6′,2′′-terpyridine-κ3N,N′,N′′)manganese(II)], C32H28N4O5Mn
Downloaded on 14.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2018-0043/html
Scroll to top button